⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
globenewswire.com
LLY
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
prnewswire.com
LLY
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
prnewswire.com
LLY
AI medical conference returns to Miami July 10-12
accessnewswire.com
LLY
Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support
globenewswire.com
LLY
Morgan & Morgan Jumps 15 Spots Into Top 25 of “Law360” 400
globenewswire.com
GOOGL
META
LLY
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
prnewswire.com
ILMN
LLY
MYGN
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
globenewswire.com
NVDA
LRCX
AMAT
SNOW
CDNS
MRVL
MU
SMCI
AMD
INTC
QCOM
GOOG
MSFT
AMZN
LLY
NTRS
REGN
GILD
BMY
PFE
MRNA
BIIB
VRTX
CRSP
EXAS
ROST
DSY
TMO
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
globenewswire.com
SGMO
LLY
AMPH
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
globenewswire.com
ABBV
ALNY
ASTL
AZN
BIIB
BMY
CSL
LLY
GILD
GSK
MRK
NVS
NVO
PFE
REGN
SNY
SUN
TEVA
UPST
VRTX